Oncology Meeting Innovations’ (OMI’s) Targeted Webinar on Chronic Lymphocytic Leukemias engages local community oncologists to discuss the current treatment options in CLL. Topics will include recently approved drugs and agents […]
Oncology Meeting Innovations’ (OMI’s) Virtual Regional Summit on B-Cell and Plasma Cell Malignancies engages local community oncologists to discuss the current treatment options in B-cell and plasma cell malignancies. Topics […]
Oncology Meeting Innovations’ (OMI’s) Targeted Webinar on Mantle Cell Leukemias engages local community oncologists to discuss the current treatment options in MCL. Topics will include recently approved drugs and agents […]
Oncology Meeting Innovations’ (OMI’s) Targeted Web Series on Genitourinary Malignancies engages local community oncologists to discuss the current treatment options in GU. Topics will include recently approved drugs and agents […]
Oncology Meeting Innovations’ (OMI’s) Targeted Web Series on Genitourinary Malignancies engages local community oncologists to discuss the current treatment options in GU. Topics will include recently approved drugs and agents […]
Oncology Meeting Innovations’ (OMI’s) Targeted Web Series on Genitourinary Malignancies engages local community oncologists to discuss the current treatment options in GU. Topics will include recently approved drugs and agents […]
More Information Coming Soon
Oncology Meeting Innovations’ (OMI’s) Targeted Webinar on Recent Advances in Urothelial Cancers engages local community oncologists to discuss the current treatment options in bladder cancer. Topics will include recently approved […]
Oncology Meeting Innovations’ (OMI’s) Virtual Regional Summit on Acute Leukemias engages local community oncologists to discuss the current treatment options in AL. Topics will include recently approved drugs and agents […]
Oncology Meeting Innovations’ (OMI’s) Virtual Regional Summit on B-Cell and Plasma Cell Malignancies engages local community oncologists to discuss the current treatment options in B-cell and plasma cell malignancies. Topics […]
Relapsed/Refractory Multiple Myeloma
CAR-T
Bispecific Antibodies